A new type of cell-based immunotherapy shows promise for B-cell lymphomas and – due to innovations in manufacturing – could make future cellular immunotherapies less expensive and more accessible to patients.
Sparing Melanoma Survivors From Overexposure to Surveillance Imaging
Immune checkpoint inhibitors are at the forefront of treatment options for melanoma, leading to durable disease control and long-term survivors. But as a result, these
June 24, 2023